Stay updated on Dara-CyBorD in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Dara-CyBorD in Myeloma: Clinical Trial page.

Latest updates to the Dara-CyBorD in Myeloma: Clinical Trial page
- Check2 days agoChange DetectedAdded related topics (Multiple myeloma and MedlinePlus Genetics) and updated the page revision from v3.3.3 to v3.3.4.SummaryDifference0.2%

- Check9 days agoChange DetectedContent related to Multiple Myeloma has been removed, along with a MedlinePlus Genetics link. This reduces disease-specific context and access to genetics background resources on the page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a Locations section listing participating U.S. states (Alabama, Arizona, Arkansas, California, Colorado, Illinois, Indiana, Kentucky, Maryland, Michigan, Nebraska, New Jersey, New York, Ohio, Oregon, South Carolina, Texas, Washington) and updated to revision v3.3.3. Removed the prior state entries and the HHS Vulnerability Disclosure notice (v3.3.2).SummaryDifference2%

- Check52 days agoChange DetectedPublication section updated to state that PubMed entries are auto-filled and may not be about the study, and the revision note now shows version v3.3.2, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded related topics 'Multiple myeloma' and 'MedlinePlus Genetics'; removed the government funding lapse notice.SummaryDifference0.4%

- Check74 days agoChange DetectedRemoved related topics 'Multiple myeloma' and 'MedlinePlus Genetics' from the page; this does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Dara-CyBorD in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-CyBorD in Myeloma: Clinical Trial page.